Funding Directory

The Small Grants program supports researchers in developing projects focused on advancing our understanding of neuroblastoma development. This initial funding can serve as a springboard for larger grant applications aimed at pioneering more effective treatment approaches.  

For more information or to apply for the funding opportunity, visit the neuroblastoma website today! 
 

Research funding to improve the health of overweight and obese people. Research should be evidence-based approaches, and effective interventions.   

For more information or to apply for the funding opportunity, visit the UKRI website today!

Funding to develop and test novel therapeutics, medical devices, diagnostics and other interventions. You can apply for academically led translational projects that aim to either: improve prevention, diagnosis, prognosis or treatment of significant health needs. Develop research tools that increase the efficiency of developing interventions. 

For more information or to apply for the funding opportunity, visit the UKRI  website today!

You have the opportunity to seek funding for initiating new endeavors or sustaining ongoing activities, or to aid your organization in responding and adjusting to emerging challenges. Funding is available for projects that aim to achieve at least one of the following objectives: fostering community connections and robust relationships, enhancing community-relevant locations, aiding individuals in realizing their full potential by providing early-stage support, and assisting people, communities, and organizations grappling with increased demands and challenges due to the cost-of-living crisis.  

For more information or to apply for the funding opportunity, visit the The National Lottery  website today!

ESRC is launching a strategic leadership hub to enhance research skills development in the social sciences, spanning academia, government, business, and the third sector. This initiative aims to innovate and simplify the delivery of training and capacity building (TCB) in research skills, fostering collaboration among providers across sectors and ensuring accessibility for researchers.

This investment is pivotal to ESRC’s commitment to fostering a diverse and inclusive research environment, supporting talent across all career stages and disciplines. The new approach focuses on coordinating and innovating research skills TCB provision, promoting lifelong learning and effective skills development from research design through to impact and engagement with research users. Key features include a federated structure led by the leadership hub, and the creation of a unified platform for accessing TCB resources.

For more information or to apply for the funding opportunity, visit the UKRI website today!

This award supports researchers in Wales collaborating with a UKCRC registered Clinical Trials Unit (CTU) to lead a funding application, with the goal of advancing toward Chief Investigator status. The program includes one-on-one mentoring, participation in CTU meetings, relevant research training, and access to expert mentoring and peer support. The Trials Development Scheme is open to researchers employed by Higher Education Institutes (HEIs) or NHS/social care organizations. HEI applicants must justify salary costs due to their existing contracts within the HEI sector. 

For more information or to apply for the funding opportunity, visit the HCRW website today!

The Commonwealth Fund's Harkness Fellowships offer a leadership development opportunity for mid-career research professionals focused on advancing health care policy and practice.

Co-funded in the UK by the NIHR and The Health Foundation, these fellowships allow recipients to spend a year in the US conducting comparative research with top US experts.

The fellowship provides funding for Fellows to:

• Deepen their understanding of the US healthcare system and policy
• Participate in leadership development activities
• Build a strong network for international collaboration

For more information or to apply for the funding opportunity, visit the NIHR website today!

The NIHR Research for Patient Benefit (RfPB) programme is inviting stage 1 applications for research proposals focused on the daily practices of health service staff, aiming to improve patient and NHS user wellbeing.

RfPB, being researcher-led, welcomes proposals on various health service issues without specifying topics.

The programme seeks to fund high-quality quantitative and qualitative research with a clear path to patient benefit, especially those involving significant interaction with patients and the public, conceived with input from relevant service user groups.

For more information or to apply for the funding opportunity, visit the NIHR website today!

The BBSRC ICURe Explore programme adapts the scientific method for commercialisation. Over three months, participants will learn to test potential customers' reactions to their ideas, products, or services. The program includes training and practice, with over 100 marketplace interviews, and helps develop transferable business and social skills. Previous participants report that the ICURe Explore support, training, and funding for customer discovery have significantly transformed their perspective on their innovations. 

For more information or to apply for the funding opportunity, visit the UKRI  website today!

This study will assess the feasibility of a randomised trial comparing hysteroscopy with polyp removal (outpatient or inpatient) to conservative management for premenopausal women with abnormal uterine bleeding and endometrial polyps. The intervention involves hysteroscopy, while the comparator is conservative medical management, defined by applicants. Recruitment should reflect the broader UK population. Key outcomes include determining patient and clinician equipoise, the acceptability of randomization, and identifying important outcomes like health-related quality of life. The study includes a randomized pilot trial to test recruitment and trial processes, alongside qualitative research to understand patient and clinician perspectives. The goal is to determine if a full-scale trial is viable and to refine its design. 

For more information or to apply for the funding opportunity, visit the NIHR website today!

This study aims to conduct a randomized controlled trial (RCT) evaluating parenting interventions for parents with learning disabilities, focusing on those from underserved populations, such as low socioeconomic backgrounds or non-native English speakers. The interventions should enhance social support and parenting skills, be previously shown effective, and be manualised for broad application. The trial will compare different interventions, with outcomes including children's developmental milestones, wellbeing, safety at home, parental confidence, and social worker concerns. Applicants should define the primary outcome, emphasize objective measures, and include a health economic evaluation. The study design includes an internal pilot phase with stop/go criteria and will focus on outcomes measurable within two to three years, with potential for longer-term follow-up. 

For more information or to apply for the funding opportunity, visit the NIHR  website today!

This randomized controlled trial (RCT) will assess intravascular lithotripsy (IVL) as part of endovascular revascularisation for patients with steno-occlusive peripheral arterial disease in the lower limbs. Participants will be stratified by TASC score and calcification severity. The intervention group receives IVL, while the control group undergoes standard revascularization without IVL. Primary outcomes include amputation-free survival, amputation rates, quality of life, hospital stay, functional ability, pain, and cost-effectiveness. Secondary outcomes include survival, adverse events, reintervention rates, and vessel patency. Core Outcomes should be included unless justified otherwise, with data reported by sex and other demographics. The trial includes an internal pilot phase to test recruitment and adherence, with clear stop/go criteria. Follow-up duration will be determined by applicants. 

For more information or to apply for the funding opportunity, visit the NIHR website today!

The Efficacy and Mechanism Evaluation (EME) Programme funds bold studies that aim to significantly advance health promotion, disease treatment, and the improvement of rehabilitation or long-term care. 

For more information or to apply for the funding opportunity, visit the NIHR website today!

The MRC-NIHR Efficacy and Mechanism Evaluation (EME) Programme is seeking applications for efficacy trials focused on improving women's health and wellbeing. Trials may address conditions unique to women or those that affect both genders but impact women differently or more severely. 

For more information or to apply for the funding opportunity, visit the NIHR website today!

The Biology to Prevention Awards aim to drive translational research that enhances biological and mechanistic understanding of cancer's causes, development, and risk, ultimately leading to precision prevention interventions. Applicants must clearly justify how their work will impact cancer risk reduction or incidence, aligning with the Prevention Research Strategy. This connection should be thoroughly considered. 

For more information or to apply for the funding opportunity, visit the CRUK website today!

NICE is updating guidance on 'Weight management: lifestyle services for overweight or obese children and young people' (PH47). The Public Health Research (PHR) Programme is particularly interested in the effectiveness and cost-effectiveness of long-term behavioral interventions for weight management in children and young people. Addressing childhood obesity is crucial, as it often leads to adult obesity and associated health issues like anxiety, depression, and social stigma. Obesity rates are highest in deprived areas, exacerbating health inequalities.

The PHR Programme seeks research evaluating population-level interventions in non-NHS settings, focusing on long-term support (over six months) for weight management. Research should consider different subpopulations, including ethnic minorities and vulnerable groups, and measure the effectiveness, cost-effectiveness, and health impact of interventions over 5-10 years. Researchers should involve service users in study design, justify their methodological approach, and include economic and policy considerations. Detailed application guidance and deadlines can be found on the PHR Programme's main funding opportunities page.

For more information or to apply for the funding opportunity, visit the NIHR website today!

This study aims to assess the feasibility of conducting a randomised clinical trial comparing surgery and conservative management for patients with tennis elbow symptoms persisting for over six months. Eligible participants are those who have experienced symptoms beyond six months. The intervention involves surgery, with the specific type defined by applicants, while the comparator is conservative management such as physiotherapy, allowing for subsequent surgery if necessary. Recruitment efforts should focus on underserved regions with a high incidence of the condition. The primary outcome is to determine the practicality of conducting a full RCT, while secondary outcomes include Patient Rated Tennis Elbow Evaluation (PRTEE) scores, quality of life measures, and work capability assessments. Conducted in secondary care settings, the feasibility study will explore factors like acceptance of randomization by patients and healthcare professionals and potential recruitment challenges. The decision to proceed with a comprehensive RCT will be based on the findings from this preliminary study. 

For more information or to apply for the funding opportunity, visit the NIHR website today!

What are the most effective interventions that organisations can adopt to improve the physical and mental health of the UK workforce? Workplace ill-health costs the UK economy billions annually, with common issues like minor illnesses, musculoskeletal conditions, and poor mental health leading to lost working days. Successful interventions require committed leadership and a preventive, proactive approach. The PHR Programme seeks research evaluating organizational-wide interventions that address health inequalities and broader health determinants, enhancing the evidence base for effective health interventions across diverse workplace contexts.

For more information or to apply for the funding opportunity, visit the NIHR website today!

The Public Health Research (PHR) Programme supports research aimed at improving public health and reducing health inequalities through non-NHS interventions.

The Rapid Funding Scheme (RFS) provides researchers with funding for rapid baseline data collection and feasibility work preceding intervention implementation. Offering an accelerated route to funding for small-scale, time-sensitive proposals, subject to scientific scrutiny.  

NIHR  

The Fund provides grants and financial support to academic researchers advancing new treatments and diagnostics for rare diseases. This funding enables research projects to stay in academia longer and progress further along the development pathway, making them more attractive to follow-on investors. 

For more information or to apply for the funding opportunity, visit the LifeArc  website today!

This grant is intended for basic science research projects exceeding £350,000 in cost or spanning more than three years. It also supports funding for studies utilizing datasets only, population and patient-based cohort studies (epidemiology), or experimental medicine studies that surpass the £350,000 threshold or extend beyond three years. 

For more information or to apply for the funding opportunity, visit the BHF website today!

Funding for research studies that address the James Lind Alliance (JLA) Priority Setting Partnerships' (PSPs) research priorities.

The JLA PSPs bring together patients, carers, and clinicians to identify key research priorities in health and care. Their goal is to ensure health research addresses the most important issues for those who use it. We are offering ongoing research funding through four of our programs, with funding rounds reopening shortly after each round closes, allowing applications at any time.

For more information or to apply for the funding opportunity, visit the NIHR website today!

This study aims to evaluate the clinical and cost effectiveness of an alternate day caplacizumab regimen compared to daily dosing in patients with immune thrombotic thrombocytopenic purpura (iTTP) who have achieved normal platelet counts. The intervention group will receive caplacizumab every other day, while the control group will continue with daily dosing, both in addition to standard care. Key outcomes include TTP relapse or exacerbation, bleeding events, and maintenance of normal platelet count. Secondary outcomes include adverse events, cost-effectiveness, and quality of life. Core Outcomes should be included unless otherwise justified, with data reported by sex and other relevant demographics. The study will be conducted in secondary care settings, featuring an internal pilot phase to assess recruitment and adherence, with clear stop/go criteria guiding progression to the full trial. Follow-up duration will be defined and justified by applicants. 

For more information or to apply for the funding opportunity, visit the NIHR  website today!

This feasibility study will evaluate whether a randomized trial comparing hysteroscopy with polyp removal (outpatient and inpatient) to conservative management is viable for treating premenopausal women with abnormal uterine bleeding diagnosed with endometrial polyps. The intervention group will receive hysteroscopy and polyp removal, while the control group will get conservative medical management, defined and justified by applicants. Key objectives include assessing equipoise from patients and clinicians, recruitment feasibility, and the acceptability of randomization. Important outcomes to determine include health-related quality of life, potential benefits and harms, and trial delivery feasibility. Applicants should report data disaggregated by sex, gender, and other demographics. The study will be conducted in any suitable setting and include a randomized pilot phase to test recruitment, adherence, and other trial processes. Qualitative research with patients and clinicians will explore their decisions and the role of hysteroscopy versus conservative management. 

For more information or to apply for the funding opportunity, visit the NIHR website today!